{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:40:43Z","timestamp":1788997243294,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11262-025-02159-x","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T04:30:48Z","timestamp":1745814648000},"page":"424-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and genetic diversity of HTLV-1 among blood donors in Jiroft, Iran: a comprehensive study"],"prefix":"10.1007","volume":"61","author":[{"given":"Fahime","family":"Edalat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Gholamzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh-al-sadat","family":"Ghoreshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Dalfardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Golkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Behboudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Arefinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"issue":"10","key":"2159_CR1","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/biom13101543","volume":"13","author":"S Nakahata","year":"2023","unstructured":"Nakahata S, Enriquez-Vera D, Jahan MI, Sugata K, Satou Y (2023) Understanding the immunopathology of HTLV-1-associated adult T-cell Leukemia\/Lymphoma: a comprehensive review. Biomolecules 13(10):1543","journal-title":"Biomolecules"},{"key":"2159_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155172","volume":"255","author":"A Gholamzad","year":"2024","unstructured":"Gholamzad A, Khakpour N, Gholamzad M, Sarvandani MRR, Khosroshahi EM, Asadi S et al (2024) Stem cell therapy for HTLV-1 induced adult T-cell leukemia\/lymphoma (ATLL): a comprehensive review. Pathol-Res Pract 255:155172","journal-title":"Pathol-Res Pract"},{"key":"2159_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2021.101594","volume":"25","author":"C Brites","year":"2021","unstructured":"Brites C, Grassi MF, Quaresma JAS, Ishak R, Vallinoto ACR (2021) Pathogenesis of HTLV-1 infection and progression biomarkers: An overview. Brazilian Journal of Infectious Diseases 25:101594","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"1","key":"2159_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/v14010152","volume":"14","author":"S Kalinichenko","year":"2022","unstructured":"Kalinichenko S, Komkov D, Mazurov D (2022) HIV-1 and HTLV-1 transmission modes: mechanisms and importance for virus spread. Viruses 14(1):152","journal-title":"Viruses"},{"issue":"3","key":"2159_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/v8030074","volume":"8","author":"C Gross","year":"2016","unstructured":"Gross C, Thoma-Kress AK (2016) Molecular mechanisms of HTLV-1 cell-to-cell transmission. Viruses 8(3):74","journal-title":"Viruses"},{"key":"2159_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fmicb.2012.00378","volume":"3","author":"C Pique","year":"2012","unstructured":"Pique C, Jones KS (2012) Pathways of cell-cell transmission of HTLV-1. Front Microbiol 3:378","journal-title":"Front Microbiol"},{"key":"2159_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12185-011-0937-1","volume":"94","author":"J Yasunaga","year":"2011","unstructured":"Yasunaga J, Matsuoka M (2011) Molecular mechanisms of HTLV-1 infection and pathogenesis. Int J Hematol 94:435\u2013442","journal-title":"Int J Hematol"},{"issue":"4","key":"2159_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006353","volume":"13","author":"G Rizkallah","year":"2017","unstructured":"Rizkallah G, Alais S, Futsch N, Tanaka Y, Journo C, Mahieux R, Dutartre H (2017) Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells. PLoS Pathog 13(4):e1006353","journal-title":"PLoS Pathog"},{"issue":"9","key":"2159_CR9","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3390\/v14092037","volume":"14","author":"TH Mulherkar","year":"2022","unstructured":"Mulherkar TH, G\u00f3mez DJ, Sandel G, Jain P (2022) Co-infection and cancer: host-pathogen interaction between dendritic cells and HIV-1, HTLV-1, and other oncogenic viruses. Viruses 14(9):2037","journal-title":"Viruses"},{"issue":"3","key":"2159_CR10","doi-asserted-by":"publisher","first-page":"BSR20211921","DOI":"10.1042\/BSR20211921","volume":"42","author":"KJ Ernzen","year":"2022","unstructured":"Ernzen KJ, Panfil AR (2022) Regulation of HTLV-1 transformation. Biosci Rep 42(3):BSR20211921","journal-title":"Biosci Rep"},{"issue":"1","key":"2159_CR11","first-page":"160","volume":"4","author":"W Zhu","year":"2021","unstructured":"Zhu W, Tsigelny IF, Kouznetsova VL (2021) HTLV-1 tax stimulates molecular events in various cancers. Fortune J Health Sci 4(1):160\u2013190","journal-title":"Fortune J Health Sci"},{"key":"2159_CR12","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1128\/MCB.24.14.6117-6126.2004","volume":"24","author":"I Lemasson","year":"2004","unstructured":"Lemasson I, Polakowski NJ, Laybourn PJ, Nyborg JK (2004) Transcription regulatory complexes bind the human T-cell leukemia virus 5\u2032 and 3\u2032 long terminal repeats to control gene expression. Mol Cell Biol 24:6117\u20136126","journal-title":"Mol Cell Biol"},{"key":"2159_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3389\/fmicb.2018.00285","volume":"9","author":"S Fochi","year":"2018","unstructured":"Fochi S, Mutascio S, Bertazzoni U, Zipeto D, Romanelli MG (2018) HTLV deregulation of the NF-\u03baB pathway: An update on tax and antisense proteins role. Front Microbiol 9:285","journal-title":"Front Microbiol"},{"issue":"26","key":"2159_CR14","doi-asserted-by":"publisher","first-page":"18750","DOI":"10.1074\/jbc.M700391200","volume":"282","author":"Y-M Kim","year":"2007","unstructured":"Kim Y-M, Ramirez JA, Mick JE, Giebler HA, Yan J-P, Nyborg JK (2007) Molecular characterization of the Tax-containing HTLV-1 enhancer complex reveals a prominent role for CREB phosphorylation in Tax transactivation. J Biol Chem 282(26):18750\u201318757","journal-title":"J Biol Chem"},{"issue":"2","key":"2159_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41379-020-00654-0","volume":"34","author":"K Yamada","year":"2021","unstructured":"Yamada K, Miyoshi H, Yoshida N, Shimono J, Sato K, Nakashima K et al (2021) Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia\/lymphoma. Mod Pathol 34(2):314\u2013326","journal-title":"Mod Pathol"},{"issue":"2","key":"2159_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/v8020034","volume":"8","author":"T Zhao","year":"2016","unstructured":"Zhao T (2016) The role of HBZ in HTLV-1-induced oncogenesis. Viruses 8(2):34","journal-title":"Viruses"},{"key":"2159_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-3-15","volume":"3","author":"M-H Cavanagh","year":"2006","unstructured":"Cavanagh M-H, Landry S, Audet B, Arpin-Andr\u00e9 C, Hivin P, Par\u00e9 M-\u00c8 et al (2006) HTLV-I antisense transcripts initiating in the 3\u2019LTR are alternatively spliced and polyadenylated. Retrovirology 3:1\u201315","journal-title":"Retrovirology"},{"key":"2159_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-8-535","volume":"8","author":"WK Neto","year":"2011","unstructured":"Neto WK, Da-Costa AC, de Oliveira AS, Martinez VP, Nukui Y, Sabino EC, Sanabani SS (2011) Correlation between LTR point mutations and proviral load levels among human T cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers. Virol J 8:1\u20137","journal-title":"Virol J"},{"issue":"9","key":"2159_CR19","doi-asserted-by":"publisher","first-page":"29912","DOI":"10.1002\/jmv.29912","volume":"96","author":"ACMM Lima","year":"2024","unstructured":"Lima ACMM, Silva DIBDS, Campos RF, de Oliveira AF, Nascimento JODS, Santana CS et al (2024) Mapping variants in HTLV-1 genome to analyze their impacts on the HAM\/TSP development: a systematic review. J Med Virol 96(9):29912","journal-title":"J Med Virol"},{"issue":"7","key":"2159_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/jmv.20807","volume":"79","author":"M Akimoto","year":"2007","unstructured":"Akimoto M, Kozako T, Sawada T, Matsushita K, Ozaki A, Hamada H et al (2007) Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers. J Med Virol 79(7):977\u2013986","journal-title":"J Med Virol"},{"key":"2159_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104765","volume":"90","author":"S Blanco","year":"2021","unstructured":"Blanco S, Frutos MC, Balangero MC, Gallego SV (2021) Human T-lymphotropic virus type 1 infection in absence of tax gene: a challenge for molecular diagnosis. Infect Genet Evol 90:104765","journal-title":"Infect Genet Evol"},{"issue":"3","key":"2159_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/nmj.NMJ_127_19","volume":"61","author":"ST Tabrizi","year":"2020","unstructured":"Tabrizi ST, Gholampour M, Zarmehri AM, Sadeghian MH, Keramati MR (2020) The frequency and risk factors of human T-cell lymphotropic virus type I among blood donors in Khorasan-e Razavi, Iran, from 2002 to 2013. Niger Med J 61(3):151\u2013155","journal-title":"Niger Med J"},{"key":"2159_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.meegid.2019.05.012","volume":"73","author":"A Mirhosseini","year":"2019","unstructured":"Mirhosseini A, Mohareri M, Arab R, Rezaee SA, Shirdel A, Koshyar MM et al (2019) Complete sequence of human T cell leukemia virus type 1 in ATLL patients from Northeast Iran, Mashhad revealed a prematurely terminated protease and an elongated pX open reading frame III. Infect Genet Evol 73:460\u2013469","journal-title":"Infect Genet Evol"},{"key":"2159_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12011-018-1613-6","volume":"191","author":"S Darroudi","year":"2019","unstructured":"Darroudi S, Abolbashari S, Ahangari N, Tayefi M, Khashyarmanesh Z, Zamani P et al (2019) Association between trace element status and depression in HTLV-1-infected patients: a retrospective cohort study. Biol Trace Elem Res 191:75\u201380","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"2159_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","volume":"52","author":"H Rafatpanah","year":"2011","unstructured":"Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S et al (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52(3):172\u2013176","journal-title":"J Clin Virol"},{"issue":"1","key":"2159_CR26","first-page":"69","volume":"9","author":"S Mohajeri","year":"2023","unstructured":"Mohajeri S, Khaleghi M, Hassanshahian M, Ravan H, Mirzaei R, Behzadi A et al (2023) Evaluating the prevalence of human T-cell lymphotropic virus in blood donors and thalassemia and hemophilia patients in Rafsanjan and Jiroft Cities of Kerman Province. Iran J Genetic Res 9(1):69\u201374","journal-title":"Iran J Genetic Res"},{"key":"2159_CR27","first-page":"14","volume":"2011","author":"K Ghadiri","year":"2010","unstructured":"Ghadiri K, Hashemian AH, Rezaei M, Payandeh M, Zare ME (2010) Serologic prevalence of human T-lymphotropic virus (HTLV) among major thalassemic patients in Kermanshah. Int J Hematol-Oncol Stem Cell Res 2011:14\u201317","journal-title":"Int J Hematol-Oncol Stem Cell Res"},{"issue":"5","key":"2159_CR28","first-page":"294","volume":"49","author":"M Davoudi","year":"2024","unstructured":"Davoudi M, Boostani R, Manzari ZS (2024) Lived experience of human t-cell leukemia virus type-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): a phenomenology study. Iranian J Med Sci 49(5):294","journal-title":"Iranian J Med Sci"},{"issue":"1","key":"2159_CR29","first-page":"9","volume":"7","author":"A Ramezani","year":"2012","unstructured":"Ramezani A, Aghakhani A, Banifazl M, Boland-Ghamat Z, Foroughi M, Gachkar L et al (2012) Frequency of human T-cell lymphotropic virus (HTLV) type 1 and 2 infection in HIV infected patients. Iran J Pathol 7(1):9\u201313","journal-title":"Iran J Pathol"},{"issue":"2","key":"2159_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5114\/hivar\/148096","volume":"23","author":"E Shahmohamadi","year":"2024","unstructured":"Shahmohamadi E, Sari AA, Mehraeen E, Nezhad MH, Karimi A, Mirzapour P et al (2024) The prevalence of HTLV-1 co-infection among people living with HIV in a tertiary care hospital in Tehran: a cross-sectional study. HIV & AIDS Rev 23(2):136\u2013140","journal-title":"HIV & AIDS Rev"},{"issue":"11","key":"2159_CR31","first-page":"2572","volume":"53","author":"R Ehsani","year":"2024","unstructured":"Ehsani R, Sharafoddin M, Olyaeemanesh A, Delavari A, Vosoogh-Moghaddam A, Alimohamadi Y, Ghorbani S (2024) Insights into health program implementation and evaluation in iran: a brief review of national healthcare programs in Iran. Iran J Public Health 53(11):2572","journal-title":"Iran J Public Health"},{"issue":"10","key":"2159_CR32","first-page":"2777","volume":"19","author":"Y Gholampour","year":"2018","unstructured":"Gholampour Y, Jaderipour A, Jeihooni AK, Kashfi SM, Harsini PA (2018) The effect of educational intervention based on health belief model and social support on the rate of participation of individuals in performing fecal occult blood test for colorectal cancer screening. Asian Pacific J Cancer Preven: APJCP 19(10):2777","journal-title":"Asian Pacific J Cancer Preven: APJCP"},{"issue":"11","key":"2159_CR33","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.3390\/v7112904","volume":"7","author":"MR Hedayati-Moghaddam","year":"2015","unstructured":"Hedayati-Moghaddam MR, Tehranian F, Bayati M (2015) Human T-Lymphotropic virus type I (HTLV-1) infection among Iranian blood donors: first case-control study on the risk factors. Viruses 7(11):5736\u20135745","journal-title":"Viruses"},{"issue":"1","key":"2159_CR34","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1038\/s41598-019-43541-8","volume":"9","author":"SH Mousavi","year":"2019","unstructured":"Mousavi SH, Khairkhah N, Bahri TD, Anvar A, Saraji AA, Behnava B et al (2019) First report of prevalence of blood-borne viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) among hemophilia patients in Afghanistan. Sci Rep 9(1):7259","journal-title":"Sci Rep"},{"key":"2159_CR35","first-page":"871","volume":"5","author":"I Ullah","year":"2017","unstructured":"Ullah I, Iftikhar T, Jadoon MA, Ur M, Khan AR, Bibi M, Urooj K (2017) Heterogeneous geographic distribution of human Tcell lymphotropic virus I (HTLV-I) and epidemiological, genomical, pathophysiologic, therapeutic knowledge about HTLV. J Entomol Zool Studies 5:871\u2013878","journal-title":"J Entomol Zool Studies"},{"issue":"1","key":"2159_CR36","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2024.42","volume":"39","author":"N Al-Bulushi","year":"2024","unstructured":"Al-Bulushi N, Al Maamari K, Alawi FB, Al-Riyami AZ, Al MA (2024) Seroprevalence of human T-cell lymphotropic virus types I\/II Among blood donors in a tertiary hospital in Oman. Oman Med J 39(1):e587","journal-title":"Oman Med J"},{"issue":"2","key":"2159_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/sccj.sccj_13_20","volume":"4","author":"FH Al-Hababi","year":"2020","unstructured":"Al-Hababi FH, Al-Deailej IM, Al-Sulatan HA, Al-Ghamdi YA, Al-Dossari KM (2020) Human T lymphotropic virus antibodies seroprevalence among healthy blood donors and high risk groups at Riyadh regional laboratory in Riyadh. Saudi Arabia Saudi Critical Care J 4(2):73\u201378","journal-title":"Saudi Arabia Saudi Critical Care J"},{"issue":"4","key":"2159_CR38","first-page":"2179","volume":"14","author":"AI Ibrahim","year":"2020","unstructured":"Ibrahim AI, Al-Musawi YA, Abdullah AI (2020) Seroprevalence of HTLV-type-1 and type-2 among Blood Donors in Some Iraqi Provinces. Indian J Forensic Med Toxicol 14(4):2179\u20132184","journal-title":"Indian J Forensic Med Toxicol"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-025-02159-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-025-02159-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-025-02159-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:08:56Z","timestamp":1757160536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-025-02159-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2159"],"URL":"https:\/\/doi.org\/10.1007\/s11262-025-02159-x","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by Jiroft University of Medical Sciences (IR.JMU.REC.1402.050).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}